Tumor Marker Blood Test Doctors Abroad — Page 9

Prof. Dr. Musa Aydınlı is an internal medicine specialist and gastroenterologist. He completed his MD at Hacettepe University in 1997. He finished internal medicine training in 2003 and gastroenterology training in 2007 at the same institution. He worked at Kayseri Training and Research Hospital from 2007 to 2009. He served in the Gastroenterology Department at Gaziantep University from 2009 to 2014. He became an associate professor in 2012 and a professor in 2020. He joined Gülhane Training and Research Hospital in 2022. He now practices at Private Koru Ankara Hospital.

Clinical focus: GERD; dyspepsia, gastritis, and Helicobacter pylori; peptic ulcer disease; celiac disease; IBS and IBD (ulcerative colitis, Crohn’s disease); colon polyps; colorectal and upper GI cancers; liver disease (fatty liver, chronic hepatitis, cirrhosis, portal hypertension); hepatobiliary and pancreatic disorders and cancers. Procedures: EGD, rectosigmoidoscopy, and colonoscopy; biopsy, polypectomy, and endoscopic mucosal resection; hemostasis and APC; dilation and stent placement; PEG; ERCP; EUS-guided biopsy.

Prof. Dr. Gül Alço is a radiation oncologist with about 27 years of experience. She treats breast, lung, prostate, gastrointestinal, gynecologic, central nervous system, head and neck, soft tissue, and bone cancers with radiotherapy.

Her expertise includes adaptive radiotherapy and radiosurgery. She uses advanced radiation techniques to provide personalized, evidence-based care in a multidisciplinary, patient-centered setting.

Dr. Siar Dursun is a pediatric neurologist at Medipol University Pendik Hospital in Istanbul. He specializes in treating complex neurological conditions in children, including epilepsy and cerebral palsy. Dr. Dursun completed his medical training at Adnan Menderes University and Izmir Research Hospital. He works at a university-affiliated center that serves 350,000 patients annually.

• Treats neurodegenerative diseases, West syndrome, and spinal muscular atrophy.
• Performs pediatric check-ups and diagnostic video-EEG monitoring for epilepsy.
• Provides medication management for autism and Parkinson’s disease.
• Practices at a hospital with 21 dedicated newborn intensive care units.

With an extensive career spanning over four decades, the doctor is a distinguished specialist in pediatrics and neonatal neurology. Following residency at Gazi University, the doctor served as an assistant professor and played a pivotal role in establishing the Pediatric Neurology Department. International experience includes clinical work at the Royal Free Hospital and Great Ormond Street Hospital in London.

The doctor is recognized for pioneering hypothermia treatment in Turkey and advancing neonatal neurocritical care. Further contributions include establishing high-risk infant monitoring clinics and founding the Turkish Childhood MS Working Group. The doctor continues to provide significant academic and clinical expertise in neurodevelopmental fields.

Dr. Ali Hakan Kaya is a hematologist at Biruni University Hospital in Istanbul. He won first prize from the Blood and Bone Marrow Transplantation Association for his research. Dr. Kaya specializes in stem cell transplants and treating complex blood cancers. He works at a TEMOS-accredited university hospital equipped with a dedicated hematology-oncology department.

• Performs allogeneic bone marrow transplants from both related and unrelated donors.
• Treats leukemia, myeloma, and various types of lymphoma using CAR T-cell therapy.
• Is a member of the Turkish Apheresis Society and the Hematologic Oncology Society.
• Received multiple awards for his scientific papers on hematologic immunology and oncology.

Professor Park Jung-won is a leading Korean specialist in hepatocellular carcinoma with over 30 years of experience. He is the Director of the Liver and Liver Cancer Center and the Integrated Cancer Care Center at Myongji Hospital. He led Korea’s first HCC guidelines in 2003. He has also overseen their updates for about 20 years. His team validated proton beam radiotherapy for liver cancer, as published in the Journal of Hepatology. He has authored more than 200 SCI-indexed papers. He also helped lead global trials, including the 2025 CheckMate 9DW study, which showed improved outcomes with nivolumab plus ipilimumab for unresectable HCC.

MD/PhD, Seoul National University; Member, National Academy of Medicine of Korea; former President, Korean Liver Cancer Association; Chair, Korean HCC Guidelines Committee; Prime Minister’s and Health Minister’s commendations; Pfizer Medical Research Award and Roche Oncology Academic Award.

Dr. Mesut Okur is a professor and chief physician at Medipol University Pendik Hospital in Istanbul. He specializes in pediatric health and diseases, with a focus on internal medical sciences. Dr. Okur has published over 25 international peer-reviewed articles. He treats children for conditions ranging from congenital heart defects to thyroid disorders.

• Published research on Down syndrome, pediatric brucellosis, and neonatal health.
• Supervises specialized medical theses on allergic rhinitis and pediatric diabetes.
• Practices at a hospital holding a Healthcare Quality Standards Certificate of 95.4%.
• Performed clinical research on pediatric voiding dysfunction and enuresis.

Dr. Svetlana Sobol is a specialist in gynecology and endocrinology at ON Clinic Kharkiv. Her work includes screening for female reproductive health through tumor marker blood tests.

• Holds a second qualification category in obstetrics and gynecology
• Graduated from Kharkiv National University named after V. N. Karazina
• Expert in gynecologist-endocrinology – the study of hormones and pelvic health
• Regularly shares medical expertise on the Healthspace YouTube channel
• Completed numerous professional training courses in women's diagnostic health

Dr. Chaitainya Borde has handled over 30,000 PET scans at HCG Manavata Cancer Centre. He is a specialist in nuclear medicine and advanced diagnostic imaging.

• Expert in nuclear scans used alongside tumor marker blood tests for cancer staging
• Managed care for over 1,000 thyroid cancer patients using specialized diagnostic protocols
• Proficient in nuclear cardiology services and complex metabolic imaging
• Author of multiple research papers published in recognized medical journals
• Specializes in Lu-177 RN therapies for targeted cancer treatment

Dr. Sridhar P.S. is a radiation oncology expert at HCG Manavata Cancer Centre. He focuses on radiotherapy and tumor marker blood test screening.

• Holds a Doctor of Medicine in radiotherapy from Banaras Hindu University
• Diplomate of the National Board in radiotherapy oncology
• Member of the Association of Radiation Oncology of India
• Member of the Society for Neuro-Oncology for brain tumor care
• Bachelors degree in medicine from Mysore University

Professor Kayihan Engin is the Director of Oncological Sciences at Medicana Bursa Hospital. He manages tumor marker blood test results within complex cancer treatment programs.

• Completed a post-doctoral fellowship at Thomas Jefferson University in the USA
• Former Coordinator of Oncological Sciences at Anadolu Medical Center in affiliation with Johns Hopkins
• Conducted cancer risk research at the National Cancer Institute in Bethesda
• Specializes in gastrointestinal, gynecological, and brain tumors
• Previously served as Chairman of Radiation Oncology at Uludağ University Medical College

Professor Metin Demirkaya leads pediatric oncology at Medicana Bursa Hospital. He specializes in identifying and treating childhood cancers through precise tumor marker blood tests.

• Treats neuroblastoma, leukemia, and Ewing's sarcoma in children
• Uses PET-CT imaging to detect and stage solid tumors
• Performs bone marrow biopsies for detailed blood disorder analysis
• Installs PORT-A-CATH systems – subcutaneous devices for simpler long-term treatment access
• Former associate professor at Bursa Uludag University School of Medicine

Professor Tolga Akman leads urological oncology at Medicana Bahcelievler Hospital. He uses tumor marker blood tests to monitor prostate, bladder, and kidney cancers.

• Professor of Medicine at a leading Turkish university-affiliated hospital
• Specializes in laparoscopic urology for minimally invasive surgical treatment
• Performs both radical and partial nephrectomies for kidney cancer care
• Expert in microsurgical procedures and pediatric urological surgeries
• Trained at Istanbul University School of Medicine in surgical urology

Professor Adil Baykan is a senior surgeon at Medistate Hospital Istanbul. He specializes in oncological surgery and identifying gastrointestinal tumors through marker tests.

• Trained at the Mayo Clinic in the USA for advanced colorectal surgery
• Practiced at St. Marks Hospital in London to master specialized surgical techniques
• Senior Professor at Ankara University medical faculty – teaches new generations of surgeons
• Published numerous research articles on colon cancer in global medical journals
• Specializes in laparoscopic surgery – using small incisions for faster patient recovery

The doctor is a highly experienced specialist in the field of neurosurgery, with a focus on advanced surgical techniques for treating complex brain and spinal disorders. With over 15 years of clinical experience, the doctor has performed numerous successful surgeries, contributing significantly to the field through innovative approaches and patient-centered care.

Graduated from a prestigious medical school and completed rigorous residency and fellowship programs. The doctor is board-certified and has published extensively in peer-reviewed journals, sharing insights and advancements in neurosurgical procedures.

Dr. Zavoloka has performed 8,000 successful surgeries and maintains a dual focus on surgical oncology and tumor marker blood test analysis.

• Heads the oncology and surgery departments at Patlazhan Clinic in Odesa
• Holds seven patents for innovative clinical techniques and surgical methods
• Treats complex conditions including breast cancer, sarcoma, glioma, and melanoma
• Defended a medical thesis as a Candidate of Medical Sciences
• Shared expertise at the ISAPS Congress in Miami and Japan

Dr. Cubillo Gracián pioneered the liquid biopsy program in Spain. He uses this specialized tumor marker blood test for molecular analysis without invasive surgery.

• Heads the Medical Oncology Service at Hospital Universitario HM Sanchinarro
• Directs postgraduate research and the Master's in Clinical and Applied Research in Oncology
• Uses molecular markers like EGFR and ALK to design targeted cancer treatment plans
• Co-investigator for the Start Madrid clinical trials program developing new cancer therapies
• Associate Professor of Oncology teaching pathology and bioethics at USP CEU